Skip to content
Business Times – Lifestyle
Author:
Applied Biologics
Applied Biologics Announces Publication of New XWRAP® Translational Research Demonstrating More Favorable Wound-Healing Biology
September 24, 2026
Applied Biologics Announces Last Patient, Last Visit in CAMPX Randomized Controlled Trial of XWRAP®
September 22, 2026
Applied Biologics Receives Service-Disabled Veteran-Owned Small Business Certification
September 17, 2026
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
September 15, 2026
Applied Biologics Welcomes CMS FDA Coordination for Innovation
September 8, 2026
Applied Biologics Achieves Key Preclinical Milestone in Disease-Modifying Osteoarthritis Gene Therapy Program
September 3, 2026
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
September 1, 2026
Applied Biologics Welcomes CMS’ Continued Commitment to Clinical Evidence in Advanced Wound Care
August 19, 2026
Applied Biologics Announces Acceptance of XWRAP® Translational Research for Presentation at SAWC Fall 2026
August 18, 2026
Applied Biologics Launches National Health System Partnership Initiative
August 12, 2026
1
2
3
Next Page
→